Cargando…

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death

BACKGROUND: Patients diagnosed with triple negative breast cancer (TNBC) have limited treatment options and often suffer from resistance and toxicity due to chemotherapy. We previously found that depleting calcium and integrin-binding protein 1 (CIB1) induces cell death selectively in TNBC cells, wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Alexander H., Leisner, Tina M., Dardis, Gabrielle J., Bivins, Marissa M., Keller, Alana L., Parise, Leslie V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360800/ https://www.ncbi.nlm.nih.gov/pubmed/30740034 http://dx.doi.org/10.1186/s12935-019-0740-2

Ejemplares similares

CIB1 prevents nuclear GAPDH accumulation and non-apoptotic tumor cell death via AKT and ERK signaling
por: Leisner, Tina M., et al.
Publicado: (2012)

Essential role of CIB1 in regulating PAK1 activation and cell migration
por: Leisner, Tina M., et al.
Publicado: (2005)

CIB1 is an endogenous inhibitor of agonist-induced integrin αIIbβ3 activation
por: Yuan, Weiping, et al.
Publicado: (2006)

Tumor growth and angiogenesis is impaired in CIB1 knockout mice
por: Zayed, Mohamed A, et al.
Publicado: (2010)

CIB1 is a Regulator of Pathological Cardiac Hypertrophy
por: Heineke, Joerg, et al.
Publicado: (2010)

Machine Learning-driven Fragment-based Discovery of CIB1-directed Anti-Tumor Agents by FRASE-bot
por: An, Yi, et al.
Publicado: (2023)

CIB1 protects against MPTP-induced neurotoxicity through inhibiting ASK1
por: Yoon, Kyoung Wan, et al.
Publicado: (2017)

CIB1 and CIB2 are HIV-1 helper factors involved in viral entry
por: Godinho-Santos, Ana, et al.
Publicado: (2016)

The Interaction between AID and CIB1 Is Nonessential for Antibody Gene Diversification by Gene Conversion or Class Switch Recombination
por: Demorest, Zachary L., et al.
Publicado: (2010)

Roles of eIF3m in the tumorigenesis of triple negative breast cancer
por: Han, Wei, et al.
Publicado: (2020)

ZMIZ2 promotes the development of triple-receptor negative breast cancer
por: Zou, Xiaopan, et al.
Publicado: (2022)

Identification of long non-coding RNA signatures in triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2018)

RNF181 modulates Hippo signaling and triple negative breast cancer progression
por: Zhou, Rui, et al.
Publicado: (2020)

Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy
por: Kundu, Manjari, et al.
Publicado: (2022)

HPV: CIB1 is for EVER and EVER
por: Notarangelo, Luigi D.
Publicado: (2018)

Depletion of histone methyltransferase KMT9 inhibits lung cancer cell proliferation by inducing non-apoptotic cell death
por: Baumert, Hannah Maria, et al.
Publicado: (2020)

Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer
por: Liu, Sainan, et al.
Publicado: (2021)

The human CIB1–EVER1–EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses
por: de Jong, Sarah Jill, et al.
Publicado: (2018)

CIB1 contributes to oncogenic signalling by Ras via modulating the subcellular localisation of sphingosine kinase 1
por: Zhu, Wenying, et al.
Publicado: (2016)

Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer
por: Lv, Xuemei, et al.
Publicado: (2019)

FOXC1-induced LINC01123 acts as a mediator in triple negative breast cancer
por: Zhang, Purong, et al.
Publicado: (2020)

Cryo–EM structure of the CRY2 and CIB1 fragment complex provides insights into CIB1-mediated photosignaling
por: Hao, Yahui, et al.
Publicado: (2022)

Novel sequential treatment with palbociclib enhances the effect of cisplatin in RB-proficient triple-negative breast cancer
por: Huang, Yajing, et al.
Publicado: (2020)

EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress
por: Zhang, Ruishan, et al.
Publicado: (2020)

Biosynthesis of selenium nanoparticles by Azoarcus sp. CIB
por: Fernández-Llamosas, Helga, et al.
Publicado: (2016)

FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A
por: Yu, Hongbo, et al.
Publicado: (2020)

SU6668 suppresses proliferation of triple negative breast cancer cells through down-regulating MTDH expression
por: Wang, Lu, et al.
Publicado: (2013)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
por: Wang, Ling, et al.
Publicado: (2018)

RPLP1 promotes tumor metastasis and is associated with a poor prognosis in triple-negative breast cancer patients
por: He, Zhixian, et al.
Publicado: (2018)

Transcriptional alterations of protein coding and noncoding RNAs in triple negative breast cancer in response to DNA methyltransferases inhibition
por: Elango, Ramesh, et al.
Publicado: (2021)

TRAIL promotes hepatocellular carcinoma apoptosis and inhibits proliferation and migration via interacting with IER3
por: Liu, Shihai, et al.
Publicado: (2021)

Suboptimal concordance in testing and retesting results of triple-negative breast carcinoma cases among laboratories: one institution experience
por: De Jesus, Jose, et al.
Publicado: (2019)

MiR-33a functions as a tumor suppressor in triple-negative breast cancer by targeting EZH2
por: Weihua, Zeng, et al.
Publicado: (2020)

Combination treatment with hENT1 and miR-143 reverses gemcitabine resistance in triple-negative breast cancer
por: Xi, Yue, et al.
Publicado: (2022)

MiR-539 inhibits proliferation and migration of triple-negative breast cancer cells by down-regulating LAMA4 expression
por: Yang, Zhi-Xue, et al.
Publicado: (2018)

Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study
por: Yi, Dandan, et al.
Publicado: (2019)

Depleting TMED3 alleviates the development of endometrial carcinoma
por: Zhang, Jin, et al.
Publicado: (2022)

LNK promotes the growth and metastasis of triple negative breast cancer via activating JAK/STAT3 and ERK1/2 pathway
por: Lv, Jianxin, et al.
Publicado: (2020)

TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway
por: Liu, Weiguang, et al.
Publicado: (2019)

PPP2R2B downregulation is associated with immune evasion and predicts poor clinical outcomes in triple-negative breast cancer
por: Li, Zheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4rgeu05ri0n9875g92g43fs9p0